Results 201 to 210 of about 1,170,360 (315)

Seasonal Variation and Genetic Evaluation of Needle Catechin Content in Half-Sib Families of <i>Pinus taeda</i>. [PDF]

Plants (Basel)
Sun J, Wang L, Liu T, Luo J, Gao C, Huang S, Zhang X, Yu J, Liu F, Cao L, Zhang Y, Liu C.   +11 more
europepmc   +1 more source

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

Molecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang, Ayesha Alvero, Yi Qin, Mingjin Wang, Alexandra Fox, Yanfeng Li, Michael Millman, Amy Kemper, Gil Mor, Xian Shuang Liu, Michael Chopp, Zheng Gang Zhang, Yi Zhang   +12 more
wiley   +1 more source

2NPLGBM: a genomic model that merges the strengths of classical and machine learning methods in genomic prediction. [PDF]

Plant Methods
Osatohanmwen BE, Vieira IC, Sharifi AR, Beissinger TM.   +3 more
europepmc   +1 more source

Genetic modification: Natural selection, articifial selection and genetic engineering

Journal of the Cameroon Academy of Sciences, 2007
No Abstract.Journal of the Cameroon Academy of Sciences Vol.
openaire   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

A comparison of different selection indexes for some economic traits in Holstein Friesian cows. [PDF]

J Anim Sci Technol
Kassab RA, Adenaike AS, Hamed MF, El-Baraby AEM, Mehrez AE, El-Magd AA, Abolude AT, Peters SO, Khattab AS.   +8 more
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Derivation of prediction error variance for non-genotyped individuals in genomic selection. [PDF]

Front Genet
Junqueira VS, Yokoo MJ, Cardoso FF.
europepmc   +1 more source

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

Molecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic, Anne Nørremølle, Lilian Bomme Ousager, Lars van Brakel Andersen, Marie Louise Mølgaard Binderup, Mads Thomassen   +5 more
wiley   +1 more source

Predictions From Evolutionary Theory for Urban Environments. [PDF]

Evol Appl
MacPherson A, Caizergues AE, Savary P, Xu K, Messer PW, Akbar MN, Fortin MJ, Holt RD, Hoi AG, Mideo N, Ness R, Peres-Neto PR, Santangelo JS, Johnson MTJ.   +13 more
europepmc   +1 more source